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Abstract
Dietary protein restriction during pregnancy and lactation in rats impairs b-cell function and mass in neonates and leads to glucose
intolerance in adult offspring. Maternal taurine (Tau) supplementation during pregnancy in rats restores b-cell function and mass in
neonates, but its long-term effects are unclear. The prevention of postnatal catch-up growth has been suggested to improve glucose
tolerance in adult offspring of low-protein (LP)-fed mothers. The objective of this study was to examine the relative contribution of b-cell
dysfunction and insulin resistance to impaired glucose tolerance in 130-day-old rat offspring of LP-fed mothers and the effects of maternal
Tau supplementation on b-cell function and insulin resistance in these offspring. Pregnant rats were fed i) control, ii) LP, and iii) LPCTau
diets during gestation and lactation. Offspring were given a control diet following weaning. A fourth group consisting of offspring of
LP-fed mothers, maintained on a LP diet following weaning, was also studied (LP-all life). Insulin sensitivity in the offspring of LP-fed
mothers was reduced in females but not in males. In both genders, LP exposure decreased b-cell function. Tau supplementation improved
insulin sensitivity in females and b-cell function in males. The LP-all life diet improved b-cell function in males. We conclude that
i) maternal Tau supplementation has persistent effects on improving glucose metabolism (b-cell function and insulin sensitivity) in adult
rat offspring of LP-fed mothers and ii) increasing the amount of protein in the diet of offspring adapted to a LP diet after weaning may
impair glucose metabolism (b-cell function) in a gender-specific manner.
Reproduction (2013) 145 609–620

Introduction
Type 2 diabetes is a prevalent health concern worldwide
and has been predicted to affect more than 438 million
people by the year 2030 (Shaw et al. 2010). A perinatal
origin of adult disease has been suggested to contribute
to the rapid rise in type 2 diabetes. This has been
supported by epidemiological and animal studies, which
have shown a strong relationship between poor fetal
growth and subsequent development of obesity and type
2 diabetes in adult life (Hales & Barker 1992).
Protein restriction (low-protein (LP), 8%) during
pregnancy and lactation in rats has been used extensively to investigate the role of fetal environment to
determine future susceptibility to adult disease.
Offspring of rats fed a LP diet during gestation and
lactation have lower body weights and altered structure
and function of the fetal endocrine pancreas (Snoeck
et al. 1990, Dahri et al. 1991) with reduced islet size
q 2013 Society for Reproduction and Fertility
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and pancreatic insulin content (Snoeck et al. 1990, Petrik
et al. 1999, Boujendar et al. 2002), reduced islet cell
proliferation, increased islet cell apoptosis (Snoeck et al.
1990, Petrik et al. 1999), and altered islet vascularization
(Snoeck et al. 1990). Previously, we suggested that the
increase in b-cell apoptosis and decrease in neogenesis
are due to the decrease in insulin-like growth factor 2
(IGF2) expression (Petrik et al. 1999). Moreover, the
insulin-secretory capacity of fetal b-cells in response to
secretagogues from LP-fed rat mothers is also significantly reduced (Dahri et al. 1991, Cherif et al. 1998).
Despite changing to a control diet after birth or after
weaning, b-cell dysfunction (as shown by a lower insulin
response after a glucose challenge) persists into late
adulthood in males (Dahri et al. 1995, Minana-Solis
Mdel & Escobar 2008) and females (Dahri et al. 1995),
suggesting that events in the fetal and early postnatal
growth periods can predispose subjects to glucose
intolerance and diabetes in adult life.
DOI: 10.1530/REP-12-0388
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LP exposure during pregnancy and lactation affects
insulin sensitivity in the adult offspring. Male and female
offspring of LP-fed mothers have been reported to exhibit
altered hepatic expression of enzymes involved in the
regulation of glucose homeostasis (Desai et al. 1997).
LP exposure during early life has also been shown to
affect the expression and activation of key proteins
involved in the insulin signaling cascade in peripheral
tissues in adult males (Ozanne et al. 1997, 2003,
Garcia-Souza et al. 2008, Chamson-Reig et al. 2009)
and females (Fernandez-Twinn et al. 2005).
Although both b-cell dysfunction and insulin resistance
contribute to diabetes, it is unclear which is prevalent in
this model of dietary restriction. Previously, our laboratory
observed for the first time that at 130 days of age (young
adulthood), LP offspring of both sexes showed signs of
impaired glucose tolerance and this deterioration was
gender specific. Specifically, males exhibited decreased
insulin sensitivity as calculated by the homeostatic model
assessment (HOMA) index, while females exhibited
reduced b-cell mass (Chamson-Reig et al. 2009).
Moreover, maternal protein deprivation leads to
alteration in the plasma amino acid profiles in both the
mother and fetus. Taurine (Tau), a non-essential amino
acid, has been found to be markedly reduced by a LP
diet, especially in fetal serum (Reusens et al. 1995). Tau
is a sulfur-containing amino acid that is present in high
concentrations in tissues, but is not incorporated into
proteins or used for energy production. It has been found
to be important for normal fetal development (Sturman
1993, Lourenco & Camilo 2002) and is dependent
on placental transfer from the mother (Huxtable 1992).
Tau has trophic effects in the developing endocrine
pancreas. The physiological role of Tau is not fully
understood, but Tau is known to be involved in a
variety of biological processes such as osmoregulation,
oxidative stress inhibition, and bile salt formation
(Bouckenooghe et al. 2006).
Previously, we also demonstrated that maternal Tau
supplementation in LP diets prevents the loss of b-cell
mass by enhancing b-cell proliferation, increasing IGF2
expression and islet vascularization, and decreasing
b-cell apoptosis in fetal islets (Boujendar et al. 2002,
2003). Whether this beneficial effect of Tau persists
until adulthood is unclear. One study has shown that
maternal Tau supplementation restores insulin response
to a glucose challenge in 11-week-old female offspring
of LP-fed dams, although unnecessary supplementation
of Tau to control animals could have detrimental
effects including weak glucose intolerance (Merezak
et al. 2004). The same authors have shown that
maternal and fetal plasma glucose levels are not
altered by maternal protein restriction; however,
plasma amino acid profiles are perturbed, and plasma
concentration of Tau and its synthesis are decreased in
both the mother and fetus (Reusens et al. 1995).
Supplementation of maternal LP diet with Tau (2.5% in
Reproduction (2013) 145 609–620

the drinking water as in the present study) normalizes
its concentration in the fetal plasma (Sturman 1993,
Lourenco & Camilo 2002). A recent study has
demonstrated that the addition of Tau to a similar
model of maternal protein restriction prevents
decreased pancreatic islet mass and reduced insulinsecretory responses to glucose load, possibly through
the prevention of mitochondrial dysfunction in the
b-cells (Lee et al. 2011).
In addition to fetal growth restriction, it has been
suggested that postnatal catch-up growth due to changes
in the environment (changes to the diet) following
growth restriction may increase the susceptibility to
diseases such as type 2 diabetes and hypertension
(Forsen et al. 2000, Hales & Barker 2001). One theory
has proposed to explain these findings through the
predictive adaptive response (Gluckman & Hanson
2006), which states that the fetus is constantly interpreting the environment created by the maternal milieu and
placental function and predicts the environment into
which it is likely to be born. However, this prediction can
be detrimental when inadequate or excessive nutrients
are present following birth. In the present study, in adult
offspring at 130 days of age, we i) investigated the site of
glucose homeostasis deterioration by maternal protein
deprivation using the gold standard hyperinsulinemic–
euglycemic clamp (insulin sensitivity) and hyperglycemic clamp (b-cell function), ii) investigated whether
Tau supplementation during gestation and lactation can
prevent the adverse effects of maternal LP diet on glucose
metabolism (b-cell function and insulin sensitivity),
iii) determined whether maintaining protein restriction
throughout life (i.e. maintaining a LP diet after weaning
in the offspring) has beneficial effects, and iv) determined whether all of these effects (1, 2, and 3) are
gender specific.

Results
In both tables and figures, letters indicate significant
differences between the groups – a, LP vs CONT; b,
LPCTau vs CONT; c, LP-all life vs CONT; d, LPCTau vs
LP; e, LP-all life vs LP; and f, LPCTau vs LP-all life.
Table 1 Body weight, fasting plasma glucose, and fasting plasma insulin
levels (meansGS.E.M.) in 130-day-old male rats.
CONT
(nZ7)
Body weight (g)
590G32
Fasting plasma
7.3G0.3
glucose (mmol/l)
Fasting plasma
384G46
insulin (pmol/l)

LP
(nZ7)

LPCTau
(nZ9)

LP-all life
(nZ10)

466G19a 509G15b,d
6.3G0.2a 6.8G0.1

445G13c
7.1G0.3

231G64a 221G49.5b

205G32c

a, LP vs CONT; b, LPCTau vs CONT; c, LP-all life vs CONT; and d, LPC
Tau vs LP.
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Table 2 Body weight, fasting plasma glucose, and fasting plasma insulin
levels (meansGS.E.M.) in 130-day-old female rats.
CONT
(nZ7)
Body weight (g)
328G10
Fasting plasma
6.6G0.1
glucose (mmol/l)
Fasting plasma
154G18
insulin (pmol/l)

LP
(nZ7)

LPCTau
(nZ9)

LP-all life
(nZ10)

273G8a 293G13b,d
6.8G0.4 7.1G0.3

265G9c
6.7G0.5

159G15

163G6

135G21

a, LP vs CONT; b, LPCTau vs CONT; c, LP-all life vs CONT; and d, LPC
Tau vs LP.

Body weight and blood parameters
We conducted a two-way ANOVA to determine the
effects of sex and treatments on body weight and fasting
glucose and insulin levels, and as expected, both male
and female offspring of all the LP-treated groups had a
significantly lower body weight than the control (CONT)
group (a, P!0.01; b, P!0.05; and c, P!0.001).
Supplementation with Tau during gestation and lactation
partially prevented the reduced body weight associated
with a LP diet (d, P!0.05) in both females and males
(Tables 1 and 2). In males, fasting glucose levels were
significantly lower in the LP rats (a, P!0.01). Fasting
insulin levels were lower in all the LP-treated groups than
in the CONT group (a, b and c, P!0.05). In females, no
differences were observed in fasting blood glucose or
insulin levels (Tables 1 and 2). There was no interaction
between sex and treatments for any of the measures.
Hyperinsulinemic–euglycemic clamp
In males, basal glucose levels were significantly
decreased in the LP group vs the CONT and LP-all life
groups (a and e, P!0.05; see Fig. 1 for the protocol
scheme). No significant differences in plasma glucose
levels were observed during the clamp (Fig. 2A).
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In females, plasma glucose levels were not different
between the treatments during either the basal period or
the clamp (Fig. 2B). Glucose infusion (Ginf) rate during
the last 30 min of the 90 min of the hyperinsulinemic–
euglycemic clamp is an indicator of whole-body insulin
sensitivity. In males, the Ginf showed no significant
differences in any of the groups (Fig. 2C). In females, the
Ginf was significantly increased in the LPCTau group vs
the LP and LPCTau groups vs the LP-all life group
(d and f, P!0.01; Fig. 2D). In males, the LPCTau and
LP-all life groups had significantly lower basal insulin levels
than the control group (b and c, P!0.05; Fig. 2E). No
changes in insulin levels were observed in females during
the basal period and the clamp in any of the groups (Fig. 2F).
During the clamp, plasma insulin levels were
markedly elevated in all the groups due to insulin
infusion and no significant differences were observed
between the groups.
During the basal period, endogenous glucose production (EGP) was equal to glucose utilization and
was lower in the LP group than in the other groups in
males (a and e, P!0.01; d, P!0.05; Fig. 3A). Females
did not show differences between the groups in the basal
state (Fig. 3B).
During the clamp, we were able to maintain low level
(!30%) fluctuation in plasma glucose-specific activity
from the basal state, which prevented significant error in
the calculation of glucose production. Hepatic insulin
sensitivity is measured as the capacity of insulin to
suppress EGP in the basal state. In males, LP exposure
tended to decrease the ability of insulin to suppress EGP
from basal (43G11% in the CONT group vs 24G14% in
the LP group), whereas this tendency was not observed in
the other groups (LPCTau and LP-all life groups; Fig. 3A).
In females, no differences in EGP were observed
between the groups during the clamp (Fig. 3B).

Experimental protocol

0

90
3-[

3H]

300

180 210

glucose

Hyperglycemic
clamp

Recovery
period

Hyperinsulinemic
clamp

390

Time (min)
Glucose
bolus

3-[3H]
bolus

Insulin (5 mU/
kg per min)

Variable
radiolabeled
glucose infusion
to maintain
euglycemia
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Continue
radiolabeled
glucose for 30
min to prevent
hyperglycemia

Cold glucose bolus
plus variable cold
glucose infusion to
elevate plasma
glucose to ~17 mM

Figure 1 Schematic of the experimental protocol.
The details are given in the Materials and Methods
section. Briefly, the hyperinsulinemic clamp with
glucose tracer methodology was performed to
determine whole-body, hepatic, and peripheral
insulin sensitivity, whereas the hyperglycemic
clamp was performed to determine pancreatic
b-cell secretory function.
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In LPCTau males, glucose utilization during the
clamp was significantly higher (b, P!0.01) than that in
the CONT group and was also higher (f, P!0.05) than
that in the LP-all life group (Fig. 3C). In females, there
was a significant decrease in glucose utilization during
the clamp in the LP group vs the CONT group
(a, P!0.01). In the LPCTau group, this decrease was
completely prevented (d, P!0.05; Fig. 3D), whereas
the LP-all life group was not different from the LP group
(e, PO0.05).
The sensitivity index (M/I (glucose metabolism (M)
divided by plasma insulin (I)) index) was calculated by
dividing the Ginf by plasma insulin levels during the last
30 min of the hyperinsulinemic–euglycemic clamp. In
male offspring, the two-way ANOVA showed that the M/I
index was not significantly different from that of the
CONT group in both the LP and LP-all life groups.
Interestingly, the M/I index was significantly increased in
the LPCTau group vs the CONT group (b, P!0.01;
Fig. 4A). In females, the M/I index was significantly
decreased in the LP and LP-all life groups than in the
LPCTau group (d, P!0.01; f, P!0.05), suggesting that
maternal supplementation with Tau restored the M/I
Reproduction (2013) 145 609–620

Figure 2 Plasma glucose levels, glucose infusion
rate (Ginf), and plasma insulin levels during the
hyperinsulinemic–euglycemic clamp in males
(A, C and E) and females (B, D and F) at 130 days of
age. Offspring of Wistar rats born to mothers fed a
control diet (CONT), a low-protein (LP) diet, or a LP
diet with taurine (LPCTau) were used in the study.
Pups were fed a normal chow diet following
weaning. A subset of LP rats was maintained on a
LP diet following weaning (LP-all life). In males,
basal plasma glucose levels were reduced in the LP
group vs the C group and the LP group vs the LP-all
life group (A). The Ginf showed no significant
differences between the groups (C). Basal plasma
insulin levels were significantly reduced in the
LPCTau and LP-all life groups vs the C group (E).
In females, no difference in basal or clamp glucose
levels was observed between the groups (B). The
Ginf was significantly increased in the LPCTau
group vs the LP group and the LPCTau group vs the
LP-all life group (D). Basal and clamp insulin levels
were not different between the groups (F). Data are
meansGS.E.M. Number of rats studied (n)Z6–10
per group. The line indicates a period of time where
significances were found. a, LP vs CONT (P!0.05);
b, LPCTau vs CONT (P!0.05); c, LP-all life vs
CONT (P!0.05); d, LPCTau vs LP (P!0.01); e,
LP-all life vs LP (P!0.01); and f, LP-all life vs LPC
Tau (P!0.01).

index to levels comparable to those observed in the
CONT group (Fig. 4B). The difference between the LP
and LP-all life groups and the CONT group did not reach
significance (PO0.05). In females, the M/I index was
not improved in the LP-all life group vs the LP group.
Effect of LPGTau supplementation on b-cell function
Plasma glucose levels during the basal period and the
clamp were not significantly different between the
groups in males and also in females (Fig. 5A and B).
The Ginf rate indicates whether circulating insulin levels
can adequately compensate for insulin resistance. In LP
males, a lower Ginf was required to clamp glucose
at 17 mM, indicating that circulating insulin levels
were inadequate to compensate for insulin resistance
(a, P!0.05). Supplementation with Tau restored the Ginf
(d, P!0.05; Fig. 5C). In females, when compared with
the CONT group, the LP-all life group exhibited lower
glucose utilization during the clamp (c, P!0.05) and
the LP group tended to have a lower Ginf (a, P!0.1).
Moreover, supplementation with Tau was not different
from the control (Fig. 5D).
www.reproduction-online.org
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Figure 3 Endogenous glucose production (EGP) and peripheral glucose utilization during the hyperinsulinemic–euglycemic clamp in males (A and
C) and females (B and D) at 130 days of age. Offspring of Wistar rats born to mothers fed a control diet (CONT), a low-protein (LP) diet, or a LP diet
with taurine (LPCTau) were used in the study. Pups were fed a normal chow diet following weaning. A subset of LP rats was maintained on a LP diet
following weaning (LP-all life). During the basal period, endogenous glucose production (EGP) was lower in the LP group than in the other groups in
males (a, e and d) (A). Females did not show differences between the groups in the basal state (B). In males, during the clamp, glucose utilization was
significantly increased in the LPCTau group than in the CONT and LP-all life groups (b and d) (C). In females, there was a significant decrease in
glucose utilization during the clamp in the LP group vs the CONT group; this decrease was completely prevented in the LPCTau group, whereas the
LP-all life group was not different from the LP group (a and d) (D). Data are meansGS.E.M. Number of rats studied (n)Z6–10 per group. The line
indicates a period of time where significances were found. a, LP vs CONT(P!0.01); b, LPCTau vs CONT (P!0.01); d, LPCTau vs LP (P!0.05);
e, LP-all life vs LP (P!0.01); and f, LPCTau vs LP-all life (P!0.05).

In males, basal insulin levels were significantly lower
in all the LP-treated groups than in the CONT group
(a, b and c, P!0.05; Fig. 6A). Basal C-peptide levels
were significantly lower in all the LP groups (a, b and c,
P!0.05; Fig. 6C). In females, basal insulin and
C-peptide levels were not significantly different between
the groups (Fig. 6B and D).
To assess first-phase insulin secretion, a bolus of 50%
glucose was injected at the start of the hyperglycemic
clamp to elevate plasma glucose levels to 17 mM.
Plasma samples for insulin and C-peptide measurements
were taken at 2, 5, and 10 min. In males, all LP
treatments elicited a significantly lower first-phase
insulin response to glucose compared with the CONT
treatment (a, b and c, P!0.01; Fig. 6A). During this
phase, C-peptide levels in the LP group were significantly lower than those in the CONT group (a, P!0.01;
Fig. 6C). The LPCTau and LP-all life groups were not
significantly different from the LP group, suggesting that
these treatments did not prevent the impairing effect of
maternal LP on first-phase insulin response in adult
offspring (Fig. 6A and C). In females, all treatment groups
had similar first-phase insulin and C-peptide responses.
No statistical differences were observed (Fig. 6B and D).
To assess second-phase insulin secretion, plasma
insulin and C-peptide levels were measured during the
hyperglycemic clamp. In males, all the LP groups had
www.reproduction-online.org

significantly lower insulin levels than the CONT group
(a, b and c, P!0.01; Fig. 6A). C-peptide levels in the LP
group were significantly lower than those in the CONT
group (a, P!0.01; Fig. 6C). The LPCTau group had
insulin levels similar to those in the LP group, whereas
C-peptide levels in the LP-all life group were similar to
those in the CONT group (Fig. 6A and C). In females,
insulin and C-peptide levels were lower in the LP-all life
group vs the CONT group (c, P!0.01). LP and LPCTau
levels were lower, but not statistically significant vs
CONT (Fig. 6B and D).
The C-peptide-to-insulin ratio is an index of insulin
clearance. In neither males nor females, the C-peptideto-insulin ratio was significantly different between the
groups (data not reported).
The disposition index (DI), which represents the
ability of the b-cell to compensate for insulin resistance,
was calculated by multiplying the sensitivity index
calculated from the hyperinsulinemic–euglycemic
clamp (Ginf divided by insulin during the last 30 min
of the clamp) by C-peptide levels (measured during the
hyperglycemic clamp). The insulin sensitivity index
calculated from the hyperglycemic clamp (Ginf/insulin)
was not used to calculate the DI, since it is well known
that insulin sensitivity assessed by the hyperinsulinemic–
euglycemic clamp is a more accurate measure. In males,
the two-way ANOVA showed that the DI was lower in
Reproduction (2013) 145 609–620
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Figure 4 Sensitivity index calculated during the hyperinsulinemic–
euglycemic clamp in males (A) and females (B) at 130 days of age.
Sensitivity index (SI) was calculated as glucose infusion rate (Ginf)
divided by plasma insulin during the last 30 min of the hyperinsulinemic–euglycemic clamp. Units of sensitivity index are milligram per
minute glucose infusion per picomole per liter insulin. Offspring of
Wistar rats born to mothers fed a control diet (CONT), a low-protein
(LP) diet, or a LP diet with taurine (LPCTau) were used in the study.
Pups were fed a normal chow diet following weaning. A subset of LP
rats was maintained on a LP diet following weaning (LP-all life). Data
are meansGS.E.M. Number of rats studied (n)Z6–10 per group. b, LPC
Tau vs CONT (P!0.01); d, LPCTau vs LP (P!0.01); and f, LP-all life vs
LPCTau (P!0.05).

the LP group vs the CONT group (a, P!0.001) and
higher in the LPCTau and LP-all life groups than
in the LP group (d and e, P!0.001; Fig. 7A). In females,
the DI was significantly lower in all the LP-treated
groups than in the CONT group (a and c, P!0.001; b,
P!0.05; Fig. 7B).

Discussion
In the present study, using the hyperinsulinemic–
euglycemic and hyperglycemic clamps in males and
females, we investigated whether i) LP exposure during
fetal and neonatal life affects insulin sensitivity and/or
b-cell function in adult offspring, ii) maternal supplementation with Tau in early life protects against the
adverse effects of protein deprivation on insulin
Reproduction (2013) 145 609–620

sensitivity and/or b-cell function at 130 days, and
iii) LP exposure throughout life affects insulin sensitivity
and/or b-cell function in 130-day-old adult offspring.
Previous studies have demonstrated that LP exposure
during early life can alter insulin sensitivity in adult male
(Ozanne et al. 1996, 2003, Shepherd et al. 1997, Sugden
& Holness 2002) and female (Merezak et al. 2004,
Fernandez-Twinn et al. 2005, Chamson-Reig et al. 2009)
offspring. However, whether LP exposure decreases
(Sugden & Holness 2002, Fernandez-Twinn et al. 2005,
Zambrano et al. 2006) or increases (Ozanne et al. 1996,
Shepherd et al. 1997, Merezak et al. 2004) insulin
sensitivity is not completely clear. The increase in insulin
sensitivity may result from chronic adaptation to a lower
b-cell function (Sugden & Holness 2002, Merezak et al.
2004). The effect of LP exposure on insulin sensitivity
appears to be greatly dependent on the age at which the
offspring are studied (Ozanne et al. 1996, 2003).
Previously, our laboratory showed that at 130 days of
age, male offspring of LP-fed mothers have higher fasting
insulin levels and exhibit insulin resistance as calculated
by the HOMA index, whereas LP females do not show
changes in insulin sensitivity compared with the controls
(Chamson-Reig et al. 2009). To further explore these
findings, we performed the gold standard hyperinsulinemic–euglycemic clamp at 130 days of age to assess for
changes in insulin sensitivity in LP offspring. In contrast
to our previous findings, we observed that males fed a LP
diet during gestation and lactation had decreased basal
insulin and glucose levels. The reason for this discrepancy is not completely clear; however, it may that the
longer duration of fasting in the present study may have
affected gluconeogenesis in the LP rats due to a lack of
amino acid substrates from muscle. Fetal protein
malnutrition has been found previously to result in low
muscle mass (Fortman et al. 2005, Rehfeldt et al. 2012).
In the previous study, the hyperinsulinemic–euglycemic
clamp technique was not used. Using this technique,
another study performed in 20-week-old male offspring
of LP-fed mothers found that whole-body insulin
sensitivity was not affected, but insulin secretion during
intravenous glucose tolerance test (IVGTT) was reduced,
similar to the present study (Lee et al. 2011). However, in
accordance with our previous study showing HOMAevaluated insulin resistance, LP males tended to show
reduced suppression of EGP (hepatic insulin resistance).
Since basal EGP was lower in LP male rats, the possibility
cannot be excluded that the decrease in suppression may
also be due to the initial reduction in basal EGP. In
contrast to hepatic insulin sensitivity, peripheral insulin
sensitivity as indicated by glucose utilization was
reduced in LP females. The mechanisms of the sexual
dimorphism involved in the observed change in insulin
sensitivity with LP exposure are unclear, as alterations in
components of the insulin signaling cascade in peripheral insulin-sensitive tissues have been documented in
both male (Ozanne et al. 1997, 2003, Garcia-Souza
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with these findings, our study has shown that a LP diet
during gestation and lactation leads to offspring with a
decreased insulin-secretory response to glucose. In
males, the LP group had significantly lower insulin and
C-peptide levels during the hyperglycemic clamp,
indicating reduced insulin secretion. In females, the
same tendency was observed, but it did not reach
statistical significance. In vivo, it is important to evaluate
insulin secretion in the context of insulin resistance,
since the normal b-cell compensates for insulin resistance by increasing insulin secretion, independent of
plasma glucose. In subjects with normal glucose
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Figure 5 Plasma glucose levels and glucose infusion
rate (Ginf) during the hyperglycemic clamp in males
(A and C) and females (B and D) at 130 days of age.
Plasma glucose levels were raised to w17 mM in all
the groups. Offspring of Wistar rats born to mothers
fed a control diet (CONT), a low-protein (LP) diet, or
a LP diet with taurine (LPCTau) were used in the
study. Pups were fed a normal chow diet following
weaning. A subset of LP rats was maintained on a LP
diet following weaning (LP-all life). In males,
supplementation with Tau restored the Ginf (C). In
females, when compared with the CONT group, the
LP-all life group exhibited lower glucose utilization
during the clamp (D). Data are meansGS.E.M.
Number of rats studied (n)Z6–10. The line
indicates a period of time where significances were
found. a, LP vs CONT (P!0.05); c, LP-all life vs
CONT (P!0.05); and d, LPCTau vs LP (P!0.05).
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et al. 2008, Chamson-Reig et al. 2009) and female
(Fernandez-Twinn et al. 2005) offspring of LP-fed
mothers.
It has been reported that a LP diet given during
fetal and neonatal life induces abnormal development
of the endocrine pancreas. b-Cell mass and islet size
are reduced (Snoeck et al. 1990, Dahri et al. 1991,
Chamson-Reig et al. 2009). Furthermore, islet cell
proliferation is decreased, and islet cell apoptosis is
increased (Snoeck et al. 1990, Petrik et al. 1999), effects
that have been linked to decreased expression of IGFs in
LP fetuses and neonates (Petrik et al. 1999). In agreement
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Figure 6 Plasma insulin and plasma C-peptide levels
during the hyperglycemic clamp in males (A and C)
and females (B and D) at 130 days of age. Offspring
of Wistar rats born to mothers fed a control diet
(CONT), a low-protein (LP) diet, or a LP diet with
taurine (LPCTau) were used in the study. Pups were
fed a normal chow diet following weaning. A subset
of LP rats was maintained on a LP diet following
weaning (LP-all life). Data are meansGS.E.M.
Number of rats studied (n)Z6–10. The line indicates
a period of time where significances were found.
During the basal period (first two points on the
graphs). a, LP vs CONT (P!0.05); b, LPCTau vs
CONT (P!0.05); and c, LP-all life vs CONT
(P!0.05). During the first and second phases of
insulin secretion. a, LP vs CONT (P!0.01);
b, LPCTau vs CONT (P!0.01); and c, LP-all
life vs CONT (P!0.01).
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Figure 7 Disposition index in males (A) and females (B) at 130 days of
age. Offspring of Wistar rats born to mothers fed a control diet (CONT),
a low-protein (LP) diet, or a LP diet with taurine (LPCTau) were used
in the study. Pups were fed a normal chow diet following weaning.
A subset of LP rats was maintained on a LP diet following weaning
(LP-all life). Data are meansGS.E.M. Number of rats studied (n)Z6–10.
a, LP vs CONT (P!0.001); b, LPCTau vs CONT (P!0.05); c, LP-all life
vs CONT (P!0.001); d, LPCTau vs LP (P!0.001); and e, LP-all life vs
LP (P!0.001).

tolerance, insulin secretion and sensitivity are linked
through a hyperbolic relationship (Bergman et al. 1981,
Kahn et al. 1993), i.e. the product of insulin secretion
and insulin sensitivity is a constant. This constant is
known as the DI and is a measure of b-cell function
(including the ability of the b-cell to compensate for
insulin resistance). In females, the sensitivity index
tended to be lower in the LP group than in the control
group, although it did not reach statistical significance.
Thus, the decrease in absolute insulin and C-peptide
levels may not have reached significance in this group
because of attempted compensation for insulin resistance. In males, LP exposure did not affect insulin
sensitivity, which is why levels of C-peptide and insulin
and the DI were all significantly reduced. The DI, which
we have validated against ex vivo glucose-stimulated
insulin secretion in islets (Tang et al. 2007), shows that,
indeed, LP exposure during gestation and lactation leads
to impaired b-cell function in both male and female
adult offspring. Furthermore, we have also shown that in
Reproduction (2013) 145 609–620

isolated islets the intrinsic mechanisms that regulate the
secretion of both insulin and glucagon are altered in
LP males at 130 days of age, due to an impaired GABA,
a receptor system that maybe another contributing
factor to the b-cell dysfunction observed in this study
(Durst et al. 2012).
Tau is an amino acid that has been shown to be
severely reduced in both maternal and fetal plasma
(Reusens et al. 1995) as well as in fetal islets during
maternal protein restriction. We also measured Tau
levels in the pancreas by HPLC and found that, at day 1,
the offspring of LP-fed mothers had significantly lower
levels of Tau (P!0.001) than those of control-treated
mothers and that, at 130 days, no difference was
observed upon return to a control diet (Supplementary
Figure 1, see section on supplementary data given at the
end of this article). Tau addition to a maternal LP diet has
been found to restore Tau concentration in the fetal
plasma and increase b-cell mass and insulin secretion
of the fetal islets (Cherif et al. 1998). Previously, our
laboratory showed that maternal Tau supplementation
prevents the decrease in b-cell mass (Boujendar et al.
2002) and vascularization of the fetal islets (Boujendar
et al. 2003) induced by LP exposure. Importantly,
previous studies by other groups had shown that Tau
supplementation to a control group (CCTau group)
had no effect on endocrine and b-cell mass at day 21
(fetal life) compared with the control group without Tau
supplementation (Boujendar et al. 2002). Furthermore,
supplementation of Tau to control rats did not change the
volume and numerical densities of islet blood vessels at
birth (Boujendar et al. 2003); however, unnecessary
supplementation of Tau can have deleterious effects such
as weak glucose intolerance when given to rats that were
fed a control (20%) protein diet (Merezak et al. 2004).
Thus, we wished to further investigate whether the
beneficial effect of maternal Tau supplementation in
offspring of LP-fed dams persists until adulthood. In this
study, we demonstrated that in both genders, maternal
Tau supplementation improves glucose metabolism in
adult LP offspring. In males, Tau supplementation tended
to improve hepatic insulin sensitivity (measured by %
suppression of EGP from the basal state) and increase
whole-body insulin sensitivity above that of the controls.
Calculation of the DI, which, as discussed above, is an in
vivo measure of b-cell function, shows that Tau
supplementation completely prevents the adverse effects
of LP exposure on b-cell function in males. This is similar
to the findings reported by Lee et al. (2011), although
unlike their study, no effect of Tau on first-phase insulin
secretion was observed. In females, Tau supplementation
protected against the adverse effects of LP exposure
on glucose utilization and overall insulin sensitivity.
In males, on the other hand, Tau supplementation only
protected against the adverse effects of LP exposure on
b-cell function, as indicated by the DI. Thus, it appears
that in males, Tau is mainly improving b-cell function,
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whereas in females, the predominant effect of Tau is in
peripheral insulin-sensitive tissues.
How exactly Tau improves b-cell function and
insulin sensitivity in the LP offspring is unclear. Tau
has been implicated in osmoregulation, inhibition of
protein phosphorylation, and calcium modulation
(Huxtable 1992, Hansen 2001). Tau has also been
shown to act as an antioxidant (Huxtable 1992) and has
been reported to reduce reactive oxygen species in islets
exposed in vivo to hyperglycemia (Tang et al. 2007) or fat
(Oprescu et al. 2007). In vivo and in vitro, Tau prevents
damage to fetal b-cells induced by IL1B (IL1b) and NO
(Merezak et al. 2001) and protects islets from cytokine
toxicity in 110-day-old female offspring of LP-fed
mothers (Merezak et al. 2004). Our laboratory further
showed that maternal Tau supplementation delays the
onset of diabetes in non-obese diabetic mice (Arany
et al. 2004). Both inflammation (Hotamisligil 2006) and
oxidative stress (Evans et al. 2003) have been implicated
in type 2 diabetes. Thus, it is possible that LP exposure
increases the susceptibility of tissues to cytokines and
oxidative stress and that maternal Tau supplementation
protects against these effects. Recently, it has been
reported that Tau can enhance mitochondrial metabolic
function. Tau may be incorporated into the mitochondria
through a putative mitochondrial Tau transporter (Suzuki
et al. 2002). In b-cells overexpressing uncoupling
protein 2 (which is upregulated in obesity-related type
2 diabetes), Tau increases mitochondrial Ca2C influx
through the Ca2C uniporter, leading to enhanced
mitochondrial metabolic function, and the ATP:ADP
ratio and restores glucose-stimulated insulin secretion
(Han et al. 2004). Mitochondrial dysfunction has been
linked to type 2 diabetes (Hojlund et al. 2008). Indeed, it
has recently been shown that LP exposure alters
mitochondrial function and Tau prevents this effect
(Lee et al. 2011). Whatever be the mechanism whereby
LP exposure affects b-cell function and insulin sensitivity
and Tau prevents these effects, the downstream pathways
mediating the phenotypic alterations should involve
epigenetic mechanisms due to the persistence of these
effects. Recently, it has been shown that maternal LP diet
decreases HNF4a expression levels in islets of offspring
via epigenetic modifications (Sandovici et al. 2011).
In addition to fetal growth restriction, it has been
suggested that postnatal catch-up growth following
growth restriction may increase susceptibility to some
diseases, such as cardiovascular diseases and metabolic
syndrome (Forsen et al. 2000, Hales & Barker 2001).
The effect of postnatal catch-up growth on glucose
metabolism is unclear. One study has reported that
20-week-old male offspring of LP-fed mothers maintained on a LP diet were more insulin sensitive than
offspring maintained on a normal diet following weaning
(Sugden & Holness 2002), suggesting a possible
detrimental effect of postnatal catch-up growth. No
differences in insulin secretion and action were reported
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in females at the same age (Sugden & Holness 2002).
Consistent with this report, we demonstrated herein
that increasing the amount of protein in the diet (the
LP group vs the LP-all life group) had detrimental effects
on glucose metabolism in males but not in females.
In males, LP-all life exposure had a tendency to increase
hepatic insulin sensitivity and increase C-peptide
levels in response to glucose during the hyperglycemic
clamp compared with LP exposure. Calculation of the
DI demonstrates that LP-all life exposure in males can
significantly improve b-cell function. The reasons for this
sexual dimorphism are still unclear.
In summary, our study demonstrates that i) early-life
protein restriction impairs glucose metabolism in both
male and female adult offspring; however, in males, it
mainly affects b-cell function, whereas in females, both
b-cell function and insulin sensitivity (peripheral) are
affected; ii) maternal supplementation of Tau has a
persistent effect in this model of early-life protein
restriction; and iii) increase in the protein content of
the diet after weaning may aggravate b-cell dysfunction
induced by early LP deprivation in male offspring.

Materials and Methods
Animals
Virgin female Wistar rats were caged with males overnight.
Copulation was verified the next morning by the presence of a
vaginal plug. Midnight was considered as day 0 of gestation.
Pregnant mothers were fed i) a 20% protein diet, which is the
control diet (CONT); ii) an 8% LP diet; or iii) an 8% LP diet
supplemented with 2.5% (w/v) Tau (Sigma) (LPCTau) in
drinking water. The diets were given throughout gestation and
lactation. Following weaning, all offspring were fed a normal
20% protein diet, with the exception of the iv) LP-all life group,
which continued to be fed the 8% LP diet following weaning.
In the LP diet, the balance of calories was supplied by an
increase of carbohydrates with normal fat content (Bioserv,
Frenchtown, NJ, USA). The detailed composition of this diet
has been published previously (Snoeck et al. 1990, Desai et al.
1996, Boujendar et al. 2003). At birth, litter size was restricted
to eight rats (four males and four females) with weights closest
to the litter mean in order to maintain equal growth (Boujendar
et al. 2002, 2003). Any mother that had less than eight offspring
in her litter was excluded from the study. Six to eight litters per
group were used, and one male and one female per litter were
studied. The rats were maintained at 12 h light:12 h darkness
cycles and were given free access to food and water. Body
weight was monitored throughout until 130 days of age. The
Animal Care Committees of the University of Western Ontario
and the University of Toronto approved all the procedures.

Surgery
At 130 days of age, offspring were cannulated as described
previously (Mason et al. 1999, Chintoh et al. 2009). The jugular
catheter was used for infusion and the carotid catheter for
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blood sampling. The rats were allowed at least 3 days of
postsurgery recovery before conducting the clamp studies.

Hyperinsulinemic–euglycemic clamp
Hyperinsulinemic–euglycemic clamp was performed in
w18-h overnight fasted rats. The rats were injected with a
bolus of 8 mCi [3-3H] glucose, and this was followed by a
constant infusion at 0.15 mCi/min (Perkin-Elmer, Boston, MA,
USA) for 90 min. Thereafter, the hyperinsulinemic–euglycemic
clamp was performed for 90 min. During the 30 min preceding
the clamp (‘basal period’), measurements were taken at 10-min
intervals for plasma glucose, insulin, and [3-3H] glucosespecific activity. At the onset of the clamp, a continuous
infusion of porcine insulin at 5 mU/kg per min was started,
resulting in plasma insulin levels in the postprandial range.
To maintain euglycemia during insulin infusion, a variable
infusion of 20% glucose was given through the jugular catheter
and adjusted according to glycemic determinations every
5 min. The glucose infusate was radiolabeled with 48 mCi/g
[3-3H] glucose to maintain the plasma glucose-specific activity
constant. After plasma separation, red blood cells were diluted
at a 1:1 ratio in heparinized saline (4 U/ml) and re-infused
into the rats.
At the end of the hyperinsulinemic–euglycemic clamp, the
rats were allowed to recover for 120 min. Ginf was continued
for another 30 min after insulin infusion was stopped to prevent
hypoglycemia associated with residual insulin actions
following the clamp.

Hyperglycemic clamp
Following the recovery period, a hyperglycemic clamp (17 mM
glucose) was performed for 90 min. Basal insulin and
C-peptide levels were measured at K10 and 0 min before the
start of the hyperglycemic clamp. At time 0, a glucose bolus
(50% dextrose: 0.1% of body weight) followed by a continuous
infusion of 37.5% glucose was given. Plasma glucose level was
maintained at 17 mM by adjusting the rate of Ginf according
to frequent (5 min) glycemic determinations. Plasma samples
for insulin and C-peptide measurements were taken at regular
intervals to assess both first-phase and second-phase insulin
secretion. After plasma separation, red blood cells were diluted
at a 1:1 ratio in heparinized saline (4 U/ml) and re-infused
into the rats.

Plasma assays
Plasma glucose was measured using a Beckman Analyzer II
(Fullerton, CA, USA). Plasma radioactivity from [3-3H] glucose
was determined after deproteinization with Ba(OH)2 and
ZnSO4 and subsequent evaporation to dryness. The aliquots
of [3-3H] glucose and tritiated glucose infusate were assayed
together with the plasma samples (Lam et al. 2002). Plasma
insulin and C-peptide levels were measured using Linco’s RIA
kits (St Charles, MO, USA), specific for rat insulin (but with
100% cross-reactivity with porcine insulin used for infusion)
and C-peptide respectively.
Reproduction (2013) 145 609–620

Calculations
EGP and glucose utilization during the basal period and the
hyperinsulinemic–euglycemic clamp were calculated by
standard tracer methods (Steele et al. 1956, Finegood et al.
1987). Data are presented as average values of the samples that
were taken during the 30 min preceding the clamp and during
the last 30 min of the clamp.

Insulin sensitivity
The M/I index of insulin sensitivity (De Fronzo et al. 1979)
was calculated by dividing the Ginf rate by the plasma insulin
level during the last 30 min of the hyperinsulinemic–
euglycemic clamp.

b-Cell function
b-Cell function in vivo was assessed by taking into account
insulin sensitivity, since the normal b-cell compensates for
insulin resistance. This was done by calculating the DI, which
represents the hyperbolic relationship between insulin
secretion and insulin sensitivity in normal subjects (Kahn
et al. 1993, Bergman et al. 2002). In humans, this index is
calculated as a product (a constant) of insulin secretion and
insulin sensitivity (Kahn et al. 1993, Bergman et al. 2002).
In rats, insulin secretion rate cannot be calculated because
their C-peptide kinetics has not been determined (the specific
rat C-peptide is unavailable for injection). Thus, we used the
C-peptide levels as an approximation of insulin secretion rate
as in our earlier studies (Goh et al. 2007). Previously, we
showed a hyperbolic relationship between the M/I index and
the C-peptide levels during the hyperglycemic clamp in rats
(Goh et al. 2007). The DI was calculated by multiplying the
average last 30-min M/I index (from the hyperinsulinemic–
euglycemic clamp) by the C-peptide levels during the
hyperglycemic clamp.

Statistical analysis
All analyses were conducted using either a two-way (sex and
treatment) or a one-way ANOVA for repeated measurements.
Post hoc Tukey’s tests were conducted when significant effects
were observed following an ANOVA or Mann–Whitney U tests
following a Kruskal–Wallis test. Data analyses were conducted
with the PASW version 18 (IBM, Chicago IL, USA, 2009) and
SAS version xx (Cary, NC, USA). Data are presented as
meansGS.E.M.
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This is linked to the online version of the paper at http://dx.doi.
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